Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Clinical trial NCT01141244 · COMPLETED
Trial details
- NCT number
- NCT01141244
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2013-11-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.